Metropolitan Life Insurance Company (MetLife)’s iRadimed IRMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-465
| Closed | -$20.5K | – | 1058 |
|
|
2024
Q1 | $20.5K | Hold |
465
| – | – | ﹤0.01% | 1856 |
|
|
2023
Q4 | $22.1K | Hold |
465
| – | – | ﹤0.01% | 1878 |
|
|
2023
Q3 | $20.6K | Hold |
465
| – | – | ﹤0.01% | 1885 |
|
|
2023
Q2 | $22.2K | Hold |
465
| – | – | ﹤0.01% | 1875 |
|
|
2023
Q1 | $18.3K | Hold |
465
| – | – | ﹤0.01% | 1926 |
|
|
2022
Q4 | $13.2K | Hold |
465
| – | – | ﹤0.01% | 2188 |
|
|
2022
Q3 | $14K | Hold |
465
| – | – | ﹤0.01% | 2183 |
|
|
2022
Q2 | $15.8K | Hold |
465
| – | – | ﹤0.01% | 2152 |
|
|
2022
Q1 | $20.9K | Sell |
465
-1,395
| -75% | -$62.6K | ﹤0.01% | 2074 |
|
|
2021
Q4 | $86K | Buy |
+1,860
| New | +$86K | ﹤0.01% | 2556 |
|